Projects per year
Personal profile
Personal profile
Dr. Keith Syson Chan received his BSc in Life Sciences from Queen’s University in Kingston, Ontario, Canada, and his PhD from the University of Texas Graduate School of Biomedical Sciences at MD Anderson Cancer Center in Houston. He received his postdoctoral training in cancer stem cells and immune evasion at the Institute for Stem Cell Biology and Regenerative Medicine at Stanford University in California. Dr. Chan most recently relocated to Houston Methodist with a $6 million Established Investigator recruitment grant from the Cancer Prevention and Research Institute of Texas (CPRIT).
Research interests
1. Tumor microenvironment: Immune checkpoint blockade therapy is emerging as a major treatment modality for cancer patients. However, a large fraction of patients remain non-responders. Ongoing projects is further characterizing the resistance mechanisms, e.g., i) how to turn cold tumors into hot tumors, via modulating dying cancer cell-released DAMPs and iDAMP and dendritic cell cross priming of CD8+ T cells, ii) cancer cell modulation of the immunosuppressive immune microenvironment etc
2. Cell death-induced biology: Most anti-cancer therapeutics designate cell death as the end goal, we serendipitously discovered drug-induced dying cells play a major role in inducing residual tumor cell repopulation and immunosuppression. And thus, driving therapeutic resistance. Proteomics discovery identified novel protein complexes associated with various forms of programmed cell death mechanisms. Ongoing studies will further dissect these molecular mechanisms.
3. Metastatic niche: We recently identified collagen-rich airway smooth muscle cells as a metastatic niche for cancer cell colonization in the lung. Ongoing projects will further characterize its interaction with other immune cells in the microenvironment (e.g. neutrophils, NK cells) to facilitate the process. We are building on existing RNAseq data profiling the niche and cancer cells, functionally integrating with microfluidics system in vitro and established in vivo models to study their mechanistic interactions
Education/Academic qualification
Biomedical Science, PhD, University of Texas MD Cancer Center
Award Date: Jun 30 2004
BSc, Queen's University Kingston
Award Date: May 31 2000
External positions
Professor of Cancer Biology in Urology, Weill Cornell Medicine
Aug 1 2025 → …
Research Area Keywords
- Cancer
- Immunobiology & Inflammation
Free-text keywords
- Fibroblast heterogeneity and collagen signaling
- Immunogenic cell death
- Tumor microenvironment
- Pyroptosis
- Spatial transcriptomics
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
A single-cell spatial map characterizing the stromal TME in bladder and breast early-lesions
Chan, K. S. (PI)
9/1/24 → 8/31/27
Project: Federal Funding Agencies
-
Molecular Analysis of tumors and liquid biopsies in Patients undergoing standard treatment for Bladder Cancer and correlation to clinical outcomes (MAP Bladder)
Satkunasivam, R. (PI), Chan, K. S. (Key Personnel) & Miles, B. J. (Key Personnel)
4/9/24 → …
Project: Clinical Trial
-
The stromal microenvironment as a co-organizer of bladder carcinogenesis and progression
Chan, K. S. (PI)
9/1/23 → 8/31/27
Project: Federal Funding Agencies
-
The stromal microenvironment as a co-organizer of bladder carcinogenesis and progression
Chan, K. S. (PI)
9/1/23 → 8/31/27
Project: Federal Funding Agencies
-
Spatial and mechanistic assessment of the role of stromal fibroblasts in driving emergence of aggressive prostate and bladder cancer
Chan, K. S. (PI)
9/1/23 → 8/31/27
Project: Federal Funding Agencies
-
Caspase-1–dependent pyroptosis converts αSMA+ CAFs into collagen-IIIhigh iCAFs to fuel chemoresistant cancer stem cells
Gao, H., Wong, S. Q. R., Subel, E., Huang, Y. H., Lee, Y. C., Hayashi, K., Alonzo, M. E., Karabicici, M., Hoi, X. P., Kasabyan, A., Mo, Q., Melchiode, Z., El-Zaatari, Z., Shen, S., Satkunasivam, R., Nikolos, F. & Chan, K. S., Jun 13 2025, In: Science Advances. 11, 24, eadt8697.Research output: Contribution to journal › Article › peer-review
Open Access6 Scopus citations -
Cellular senescence in precancer lesions and early-stage cancers
Hoi, X. P., Stangis, M. M., Glass, S. E., Kim, J. H., Kang, S. W., Brennen, W. N., Li, Z., Grady, W. M., Yegnasubramanian, S., Kuhn, P., Lyssiotis, C. A., Sagara, A., Shrubsole, M. J., Kadara, H., Yuan, Y., Coffey, R. J., Lau, K. S., De Marzo, A. M., Maitra, A. & Min, J. & 3 others, , Nov 6 2025, (E-pub ahead of print) In: Cancer Cell.Research output: Contribution to journal › Comment/debate › peer-review
-
The dynamic roles of the bladder tumour microenvironment
Lee, Y. C., Lam, H. M., Rosser, C., Theodorescu, D., Parks, W. C. & Chan, K. S., Sep 2022, In: Nature Reviews Urology. 19, 9, p. 515-533 19 p.Research output: Contribution to journal › Review article › peer-review
59 Scopus citations -
Cell death-induced immunogenicity enhances chemoimmunotherapeutic response by converting immune-excluded into T-cell inflamed bladder tumors
Nikolos, F., Hayashi, K., Hoi, X. P., Alonzo, M. E., Mo, Q., Kasabyan, A., Furuya, H., Trepel, J., Di Vizio, D., Guarnerio, J., Theodorescu, D., Rosser, C., Apolo, A., Galsky, M. & Chan, K. S., Dec 2022, In: Nature Communications. 13, 1, 1487.Research output: Contribution to journal › Article › peer-review
Open Access39 Scopus citations -
Discoidin Domain Receptor-Driven Gene Signatures as Markers of Patient Response to Anti-PD-L1 Immune Checkpoint Therapy
You, S., Kim, M., Hoi, X. P., Lee, Y. C., Wang, L., Spetzler, D., Abraham, J., Magee, D., Jain, P., Galsky, M. D., Chan, K. S. & Theodorescu, D., Oct 1 2022, In: Journal of the National Cancer Institute. 114, 10, p. 1380-1391 12 p.Research output: Contribution to journal › Article › peer-review
Open Access11 Scopus citations